Investing.com - Financial Markets Worldwide

Sofiva Genomics Co Ltd (6615)

TPEX
Currency in TWD
31.80
-0.50(-1.55%)
Closed·
6615 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
6615 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
31.8032.30
52 wk Range
29.0057.20
Key Statistics
Edit
Bid/Ask
51.60 / 52.50
Prev. Close
39.9
Open
32.3
Day's Range
31.8-32.3
52 wk Range
29-57.2
Volume
3.05K
Average Volume (3m)
13.43K
1-Year Change
-43.52%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6615 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 6
Prominent player in the Healthcare Providers & Services industry
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Sofiva Genomics Co Ltd Company Profile

Sofiva Genomics Co.,Ltd. provides genetic testing services in Taiwan and internationally. The company offers prenatal services, including thalassemia carrier screening; tests for microdeletion syndromes and single-gene abnormalities; detection of common chromosome abnormalities, selected microdeletions syndromes, and selected skeletal dysplasia genetic mutations; multiple genetic diseases detection; folate metabolism genetic screening; spinal muscular atrophy carrier screening; fragile X syndrome carrier screening; congenital infection screening; risk assessment for early/late-onset preeclampsia; maternal serum screening for down syndrome; and karyotyping. It also provides cancer services, such as cancer scans; real-time monitoring of tumor dynamics; hereditary cancer related genetic tests; and hereditary women's cancer tests for breast, colon, ovarian, and endometrial cancer, as well as human papillomavirus screening. In addition, the company offers rare diseases genetic testing services; and preimplantation genetic diagnosis and NGS-based preimplantation genetic screening services. Further, it provides new-born genetic testing services comprising baby scans; hereditary sensorineural hearing loss screening; congenital central hypoventilation syndrome screening; congenital cytomegalovirus infection screening test; and atopic dermatitis genetic screening. Additionally, the company offers biochemical and chromosome testing, as well as advisory and support services. It serves expectant parents, patients with genetic disorders, and their families. Sofiva Genomics Co.,Ltd. was founded in 2012 and is based in Taipei, Taiwan.

Industry
Biotechnology & Medical Research
Sector
Healthcare
0
Market
Taiwan

Compare 6615 to Peers and Sector

Metrics to compare
6615
Peers
Sector
Relationship
P/E Ratio
−94.5x31.8x−0.5x
PEG Ratio
0.730.980.00
Price/Book
1.1x1.3x2.6x
Price / LTM Sales
1.7x3.5x3.2x
Upside (Analyst Target)
-0.0%38.8%
Fair Value Upside
Unlock39.0%5.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.34%
Dividend Yield
0.94%
Industry Median 1.02%
Annualised payout
0.30
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
100.68M / --
EPS Revisions
a
a
Unlock
Last 90 days

6615 Income Statement

FAQ

What Stock Exchange Does Sofiva Genomics Trade On?

Sofiva Genomics is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for Sofiva Genomics?

The stock symbol for Sofiva Genomics is "6615."

What Is the Sofiva Genomics Market Cap?

As of today, Sofiva Genomics market cap is 686.67M.

What Is Sofiva Genomics's Earnings Per Share (TTM)?

The Sofiva Genomics EPS (TTM) is -0.34.

When Is the Next Sofiva Genomics Earnings Date?

Sofiva Genomics will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is 6615 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sofiva Genomics Stock Split?

Sofiva Genomics has split 0 times.

How Many Employees Does Sofiva Genomics Have?

Sofiva Genomics has 0 employees.

What is the current trading status of Sofiva Genomics (6615)?

As of 31 Aug 2025, Sofiva Genomics (6615) is trading at a price of 31.80, with a previous close of 39.90. The stock has fluctuated within a day range of 31.80 to 32.30, while its 52-week range spans from 29.00 to 57.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.